Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-16 · accession 0001415889-25-013641 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-19 | 2025-05-16 | FENC | Andrade Robert | CFO | A - Grant | $0.00 | +16.7K | 150.3K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares | 2025-05-16 | A | A | 16,667 | $0.00 | 150,300 | D | — | — | (F1) Represents shares released from restriction from shares awarded 5-16-2024. |